Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
808 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06301321 | The Evaluation and Comparison of BCR-ABL p210 mRNA Transcripts (%IS Unit) Results Between Dr. PCR™ BCR-ABL1 Major IS Detection Kit (Optolane) and QXDx™ BCR-ABL %IS Kit (Bio-Rad) in Chronic Myeloid Leukemia Patients(BCR-ABL1) | unknown | — | 80 | Siriraj HospitalOTHER | 1 | Mar 8, 2024 | clinicaltrials |
| NCT01120184 | A Study of Trastuzumab Emtansine (T-DM1) Plus Pertuzumab/Pertuzumab Placebo Versus Trastuzumab [Herceptin] Plus a Taxane in Participants With Metastatic Breast Cancer (MARIANNE) | completed | Phase 3 | 1,095 | Hoffmann-La Roche |
| 38 |
| Mar 4, 2024 |
| clinicaltrials |
| NCT06165328 | The Comparison Between Computed Tomography and Colonoscope in Detecting Colorectal Tumors in Patients With FIT+(CTOCOCREC) | unknown | — | 241 | Hat Yai Medical Education CenterOTHER | 1 | Feb 29, 2024 | clinicaltrials |
| NCT03694522 | A Study of Bemarituzumab (FPA144) Combined With Modified FOLFOX6 (mFOLFOX6) in Gastric/Gastroesophageal Junction Cancer(FIGHT) | completed | Phase 2 | 155 | Five Prime Therapeutics, Inc.INDUSTRY | 18 | Feb 28, 2024 | clinicaltrials |
| NCT05056064 | Efficacy of Swallowing Function After Early Postoperative Oral Exercise Among Patient With Oral Cavity Cancer Underwent Flap Reconstruction | completed | N/A | 90 | Department of Medical Services Ministry of Public Health of ThailandOTHER_GOV | 1 | Jan 25, 2024 | clinicaltrials |
| NCT05539053 | Efficacy of NAC for the Prevention and Relief of PIPN in Women With Ovarian, Tubal, and Peritoneal Cancer | completed | N/A | 60 | Department of Medical Services Ministry of Public Health of ThailandOTHER_GOV | 1 | Jan 25, 2024 | clinicaltrials |
| NCT06211010 | The Target Urine VOCs Biosensor for Genitourinary Malignancy Detection | completed | — | 64 | Suranaree University of TechnologyOTHER | 1 | Jan 18, 2024 | clinicaltrials |
| NCT00957086 | Study of Post-Op Adjuvant Concurrent Chemo-RT With or Without Nimotuzumab for Head & Neck Cancer | unknown | Phase 3 | 710 | National Cancer Centre, SingaporeOTHER | 13 | Jan 9, 2024 | clinicaltrials |
| NCT03219268 | A Study of MGD013 in Patients With Unresectable or Metastatic Neoplasms | completed | Phase 1 | 277 | MacroGenicsINDUSTRY | 8 | Dec 21, 2023 | clinicaltrials |
| NCT06169566 | The Synbiotics Effects in Polycystic Ovary Syndrome: A Randomized Controlled Trial(PCOS) | unknown | N/A | 40 | Maharaj Nakorn Chiang Mai HospitalOTHER | 1 | Dec 13, 2023 | clinicaltrials |
| NCT03871816 | A Study to Determine Frequency of DNA-repair Defects in Men With Metastatic Prostate Cancer | completed | — | 14,532 | Janssen Research & Development, LLCINDUSTRY | 25 | Dec 11, 2023 | clinicaltrials |
| NCT02422615 | Study of Efficacy and Safety of LEE011 in Men and Postmenopausal Women With Advanced Breast Cancer.(MONALEESA-3) | completed | Phase 3 | 726 | Novartis PharmaceuticalsINDUSTRY | 30 | Nov 30, 2023 | clinicaltrials |
| NCT02941926 | Study to Assess the Safety and Efficacy of Ribociclib (LEE011) in Combination With Letrozole for the Treatment of Men and Pre/Postmenopausal Women With HR+ HER2- aBC(COMPLEEMENT-1) | completed | Phase 3 | 3,246 | Novartis PharmaceuticalsINDUSTRY | 38 | Oct 24, 2023 | clinicaltrials |
| NCT02125461 | A Global Study to Assess the Effects of MEDI4736 Following Concurrent Chemoradiation in Patients With Stage III Unresectable Non-Small Cell Lung Cancer(PACIFIC) | completed | Phase 3 | 713 | AstraZenecaINDUSTRY | 26 | Oct 10, 2023 | clinicaltrials |
| NCT03302234 | Study of Pembrolizumab Given With Ipilimumab or Placebo in Participants With Untreated Metastatic Non-Small Cell Lung Cancer (NSCLC) (MK-3475-598/KEYNOTE-598) | completed | Phase 3 | 568 | Merck Sharp & Dohme LLCINDUSTRY | 24 | Sep 26, 2023 | clinicaltrials |
| NCT01685398 | Topical Timolol for Superficial Infantile Hemangioma | completed | Phase 3 | 48 | Mahidol UniversityOTHER | 1 | Sep 21, 2023 | clinicaltrials |
| NCT02312258 | A Study of Oral Ixazomib Maintenance Therapy in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Not Treated With Stem Cell Transplantation (SCT) | completed | Phase 3 | 706 | TakedaINDUSTRY | 35 | Sep 21, 2023 | clinicaltrials |
| NCT04184960 | AG & IM in CA Stomach Protocol | unknown | — | 400 | Chinese University of Hong KongOTHER | 4 | Sep 7, 2023 | clinicaltrials |
| NCT04920019 | Opioid Sparing Effect of Thoracic Epidural Analgesia for Open Upper Abdominal Surgery | completed | N/A | 140 | Mahidol UniversityOTHER | 1 | Aug 23, 2023 | clinicaltrials |
| NCT01000025 | PF-00299804 in Stage IIIB or Stage IV Non-Small Cell Lung Cancer Not Responding to Standard Therapy for Advanced or Metastatic Cancer | completed | Phase 3 | 720 | NCIC Clinical Trials GroupNETWORK | 12 | Aug 22, 2023 | clinicaltrials |
| NCT04742192 | Non-interventional, Prospective Study to Determine Prevalence of EGFR Mutations in Non-small Cell Lung Cancer(EARLY-EGFR) | completed | — | 601 | AstraZenecaINDUSTRY | 15 | Aug 14, 2023 | clinicaltrials |
| NCT03024996 | A Study of Atezolizumab as Adjuvant Therapy in Participants With Renal Cell Carcinoma (RCC) at High Risk of Developing Metastasis Following Nephrectomy(IMmotion010) | terminated | Phase 3 | 778 | Hoffmann-La RocheINDUSTRY | 28 | Aug 3, 2023 | clinicaltrials |
| NCT03185013 | REVEAL 1 (Evaluation of VGX-3100 and Electroporation for the Treatment of Cervical HSIL)(REVEAL 1) | completed | Phase 3 | 201 | Inovio PharmaceuticalsINDUSTRY | 19 | Jul 27, 2023 | clinicaltrials |
| NCT02150967 | A Phase II, Single Arm Study of BGJ398 in Patients With Advanced Cholangiocarcinoma | terminated | Phase 2 | 143 | QED Therapeutics, a BridgeBio companyINDUSTRY | 11 | Jul 3, 2023 | clinicaltrials |
| NCT02578641 | A Phase III Trial Evaluating Chemotherapy and Immunotherapy for Advanced Nasopharyngeal Carcinoma (NPC) Patients(VANCE) | completed | Phase 3 | 330 | Tessa TherapeuticsINDUSTRY | 5 | Jun 28, 2023 | clinicaltrials |
| NCT01104155 | Eribulin Mesylate in Combination With Intermittent Erlotinib in Patients With Previously Treated, Advanced Non-Small Cell Lung Cancer | completed | Phase 2 | 123 | Eisai Inc.INDUSTRY | 7 | Jun 22, 2023 | clinicaltrials |
| NCT01321554 | A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Trial of Lenvatinib (E7080) in 131I-Refractory Differentiated Thyroid Cancer (DTC)(SELECT) | completed | Phase 3 | 392 | Eisai Inc.INDUSTRY | 23 | Jun 22, 2023 | clinicaltrials |
| NCT01327885 | Phase 3 Study to Compare the Efficacy and Safety of Eribulin With Dacarbazine in Subjects With Soft Tissue Sarcoma | completed | Phase 3 | 452 | Eisai Inc.INDUSTRY | 23 | Jun 22, 2023 | clinicaltrials |
| NCT01593254 | Study of Dasatinib vs Imatinib in Patients With Chronic Myeloid Leukemia (CML) Who Did Not Have Favorable Response to Imatinib(DASCERN) | completed | Phase 2 | 262 | Bristol-Myers SquibbINDUSTRY | 15 | Jun 22, 2023 | clinicaltrials |
| NCT05901376 | MicroRNAs From Blood Samples as Biomarkers for Gastric Cancer Detection | unknown | — | 280 | King Chulalongkorn Memorial HospitalOTHER | 1 | Jun 13, 2023 | clinicaltrials |
| NCT03763565 | Effectiveness of HPV Vaccine in Thai Adult Women | completed | — | 993 | Mahidol UniversityOTHER | 1 | Jun 5, 2023 | clinicaltrials |
| NCT01698918 | Open-label, Phase II, Study of Everolimus Plus Letrozole in Postmenopausal Women With ER+, HER2- Metastatic or Locally Advanced Breast Cancer(BOLERO-4) | completed | Phase 2 | 202 | Novartis PharmaceuticalsINDUSTRY | 13 | May 3, 2023 | clinicaltrials |
| NCT05757388 | Efficacy of Parecoxib Combined With Paracetamol in Mastectomy | unknown | N/A | 60 | Khon Kaen UniversityOTHER | 1 | Apr 14, 2023 | clinicaltrials |
| NCT05559814 | Intraluminal Peppermint Oil and Adenoma Detection Rate in Screening Colonoscopy | completed | N/A | 404 | Mahidol UniversityOTHER | 1 | Apr 5, 2023 | clinicaltrials |
| NCT04208334 | The Effect of Curcumin for Treatment of Cancer Anorexia-Cachexia Syndrome in Patients With Stage III-IV of Head and Neck Cancer(CurChexia) | completed | Phase 2 | 20 | Phramongkutklao College of Medicine and HospitalOTHER | 1 | Mar 28, 2023 | clinicaltrials |
| NCT04402749 | The Incidence of Pulmonary Embolism During Nephrectomy | completed | — | 416 | Mahidol UniversityOTHER | 1 | Mar 16, 2023 | clinicaltrials |
| NCT05514561 | FIT and Fecal Calprotectin in Patients With Chronic Lower GI Symptoms | completed | — | 1,007 | Mahidol UniversityOTHER | 1 | Mar 14, 2023 | clinicaltrials |
| NCT03034603 | The Safety and Efficacy Test of Nutri-PEITC Jelly in Head and Neck Cancer Patients | completed | N/A | 96 | Dental Innovation Foundation Under Royal PatronageOTHER | 1 | Feb 15, 2023 | clinicaltrials |
| NCT00281658 | Study In Women And Men With Metastatic Breast Cancer That Have Overexpression Of ErbB2 | completed | Phase 3 | 444 | Novartis PharmaceuticalsINDUSTRY | 8 | Feb 10, 2023 | clinicaltrials |
| NCT02420821 | A Study of Atezolizumab in Combination With Bevacizumab Versus Sunitinib in Participants With Untreated Advanced Renal Cell Carcinoma (RCC)(IMmotion151) | completed | Phase 3 | 915 | Hoffmann-La RocheINDUSTRY | 21 | Jan 30, 2023 | clinicaltrials |
| NCT03499899 | A Study of Efficacy and Safety of LAG525 in Combination With Spartalizumab, or With Spartalizumab and Carboplatin, or With Carboplatin, in Patients With Advanced Triple-negative Breast Cancer | completed | Phase 2 | 88 | Novartis PharmaceuticalsINDUSTRY | 17 | Jan 30, 2023 | clinicaltrials |
| NCT02813785 | A Study of Atezolizumab Compared With Docetaxel in Non-Small Cell Lung Cancer (NSCLC) After Failure With Platinum-Containing Chemotherapy(IMpower210) | completed | Phase 3 | 565 | Hoffmann-La RocheINDUSTRY | 5 | Jan 10, 2023 | clinicaltrials |
| NCT03233360 | Hepatocellular Carcinoma Registry in Asia: The INSIGHT Registry(INSIGHT) | completed | — | 2,533 | National Cancer Centre, SingaporeOTHER | 9 | Dec 5, 2022 | clinicaltrials |
| NCT04450901 | Dose Escalation/Dose Expansion Study of YBL-006 in Patients With Advanced Solid Tumors | unknown | Phase 1 / Phase 2 | 90 | Y Biologics Inc.INDUSTRY | 3 | Dec 5, 2022 | clinicaltrials |
| NCT01568866 | Phase 3 Study With Carfilzomib and Dexamethasone Versus Bortezomib and Dexamethasone for Relapsed Multiple Myeloma Patients(ENDEAVOR) | completed | Phase 3 | 929 | AmgenINDUSTRY | 27 | Nov 14, 2022 | clinicaltrials |
| NCT03855904 | HemosprayTM for Gastrointestinal Bleeding From Cancer | unknown | N/A | 112 | King Chulalongkorn Memorial HospitalOTHER | 1 | Oct 4, 2022 | clinicaltrials |
| NCT05037539 | Efficacy of Injectable Fentanyl in Sublingual Route Versus Oral Morphine Syrup for Breakthrough Pain | completed | Phase 1 / Phase 2 | 20 | Department of Medical Services Ministry of Public Health of ThailandOTHER_GOV | 1 | Aug 31, 2022 | clinicaltrials |
Data updated 23 days agoSource updated unknownsource: clinicaltrials